back
Food Allergy Essentials
Common Allergens
Food Allergy 101
Allergy Alerts & Ingredient Notices
Back to School Headquarters
Food Allergy & Anaphylaxis Emergency Care Plan
Recipes
Free Downloadable Resources
Shop Sifter
Information for you
Newly Diagnosed
Children with Food Allergies
Adolescents and Teens
Adults with Allergies
Educators
Healthcare Providers
College Staff
Other Professionals
Join the Community
Join the FARE Community
Find a Support Group

back
Accelerating Innovation
Elevating Care
Pioneering Advances in Diagnosis
Early Introduction and Food Allergy Prevention
Developing Effective Treatments
Elevating Research
FARE Patient Registry
FARE Clinical Network
FARE Data Coordinating Center
FARE Biobank
Clinical Trials
Recently Funded Research
Research Funding Opportunities

Media Room

Releases & Statements

Statement by Sung Poblete, RN, PhD, CEO of FARE, regarding the frustration felt by the food allergy community after FDA requests additional information and testing before approving neffy®, a needle-free epinephrine alternative

September 19, 2023

FARE Celebrates New Teacher Training Law in New York

September 18, 2023

After 12 Years, Advocates and Lawmakers Secure Win for 218,000 Schoolchildren

FARE and CVS Pharmacy Partner for The Teal Pumpkin Project, Bringing Safe and Inclusive Offerings to Food Allergy Community

September 13, 2023

Beginning with the 2023 Halloween season, the partnership extends food allergy inclusivity to holidays throughout the year.

FARE’s 2023 Food Allergy Summit Welcomes Medical Specialists, Patients, Educators, and Others Who Serve People with Food Allergies and Intolerances

August 18, 2023

Statement by Sung Poblete, RN, PhD, CEO of FARE, regarding the 33 million individuals in the United States with life-threatening food allergies

August 10, 2023

CA Schools Now Safer for Food Allergy Students

August 08, 2023

California Food Allergy Resource Guide Is Now Available

Illinois Governor Pritzker Signs HB 3639 into Law, Capping Epinephrine Auto-Injector Costs at $60

August 07, 2023

Landmark Legislation Ensures Accessible and Affordable Epinephrine for All Illinois Residents

Statement of Robert Earl, Vice President, Regulatory Affairs, FARE regarding FDA’s response to the CSPI petition on manufacturers adding sesame to products in response to FASTER Act

July 27, 2023

FARE Strongly Endorses the ADINA Act (H.R. 4263/S. 2079)

June 22, 2023

Proposed Legislation Requires Labeling for Top 9 Allergens and Gluten in Prescription & OTC Medications

Statement by Sung Poblete, RN, PhD, CEO of FARE, regarding FDA’s Extended PDUFA Target Action Date for neffy® (Intranasal (IN) Epinephrine) for Allergic Reactions

June 21, 2023

Media Alert: Escape from Alcatraz Triathlete Colin Owens on Overcoming Tragedy and Surviving Food Allergies

June 06, 2023

FARE Announces $3M in Funding Opportunities to Support Innovations in Food Allergy Diagnostics and Research on Rare Food Allergy

June 01, 2023

Media Contact:

media@foodallergy.org.

About FARE

FARE (Food Allergy Research & Education) is the leading nonprofit organization that empowers the food allergy patient across the journey of managing their disease. FARE delivers innovation by focusing on three strategic pillars—advocacy, research, and education—united by the through line of health equity. FARE’s initiatives accelerate the future of food allergy through effective policies and legislation, novel strategies toward prevention, diagnosis, and treatment, and building awareness and community. For more information, visit FoodAllergy.org.